<DOC>
	<DOCNO>NCT03062150</DOCNO>
	<brief_summary>The steroid hormone cortisol release response stress act central nervous system upon glucocorticoid ( GR ) mineralocorticoid receptor ( MR ) . GR widely distribute across brain MR predominantly express hippocampus prefrontal cortex - two brain area closely related memory executive function . Stimulation MR lead increase glutamate act glutamatergic NMDA receptor hippocampus prefrontal cortex . In previous study , investigator show fludrocortisone , mineralocorticoid receptor ( MR ) agonist , improve memory executive function depress patient healthy control . However , depressed patient exhibit cognitive deficit traditional neuropsychological domain memory executive function . In addition , depression-specific alteration cognitive bias deficit social cognition , two clinically highly relevant area . Therefore , specific aim renewal proposal two-fold : - To examine whether beneficial effect fludrocortisone depressed patient extend depression-specific cognitive bias social cognition - To determine whether beneficial effect fludrocortisone depend NMDA-receptor function whether beneficial effect enhance NMDA receptor stimulation . The investigator hypothesize fludrocortisone improve cognitive bias social cognition depress patient beneficial effect depend NMDA receptor . Therefore , investigator hypothesize effect fludrocortisone enhance co-administration partial NMDA receptor agonist D-cycloserine . The study advance current knowledge examine mechanism action MR stimulation exert beneficial effect cognition extend effect depression-specific cognitive bias alteration social cognition . Furthermore , potential interaction MR NMDA receptor highly clinically relevant give promising result NMDA receptor antagonist treatment major depression .</brief_summary>
	<brief_title>Mineralocorticoid Receptor , NMDA Receptor Cognitive Function Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<mesh_term>Mineralocorticoids</mesh_term>
	<mesh_term>Fludrocortisone</mesh_term>
	<criteria>Age 1865 year Depressed male female patient accord DSMV &amp; minimum 17items Hamilton Depression Score 18 healthy control informed consent sign Current use antidepressant , antipsychotic , mood stabilizer Relevant medical neurological disorder Pregnancy unsure contraception Relevant psychiatric comorbidity ( bipolar psychotic disorder ) Active alcohol substance abuse/dependance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>